219 related articles for article (PubMed ID: 33148644)
1. Trisulfide bond-mediated doxorubicin dimeric prodrug nanoassemblies with high drug loading, high self-assembly stability, and high tumor selectivity.
Yang Y; Sun B; Zuo S; Li X; Zhou S; Li L; Luo C; Liu H; Cheng M; Wang Y; Wang S; He Z; Sun J
Sci Adv; 2020 Nov; 6(45):. PubMed ID: 33148644
[TBL] [Abstract][Full Text] [Related]
2. Probing the Superiority of Diselenium Bond on Docetaxel Dimeric Prodrug Nanoassemblies: Small Roles Taking Big Responsibilities.
Zuo S; Sun B; Yang Y; Zhou S; Zhang Y; Guo M; Sun M; Luo C; He Z; Sun J
Small; 2020 Nov; 16(45):e2005039. PubMed ID: 33078579
[TBL] [Abstract][Full Text] [Related]
3. Satellite-Type Sulfur Atom Distribution in Trithiocarbonate Bond-Bridged Dimeric Prodrug Nanoassemblies: Achieving Both Stability and Activatability.
Li L; Liu T; Zuo S; Li Y; Zhao E; Lu Q; Wang D; Sun Y; He Z; Sun B; Sun J
Adv Mater; 2024 Jan; 36(4):e2310633. PubMed ID: 37983894
[TBL] [Abstract][Full Text] [Related]
4. Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy.
Sun B; Luo C; Yu H; Zhang X; Chen Q; Yang W; Wang M; Kan Q; Zhang H; Wang Y; He Z; Sun J
Nano Lett; 2018 Jun; 18(6):3643-3650. PubMed ID: 29726685
[TBL] [Abstract][Full Text] [Related]
5. Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy.
Sun B; Luo C; Zhang X; Guo M; Sun M; Yu H; Chen Q; Yang W; Wang M; Zuo S; Chen P; Kan Q; Zhang H; Wang Y; He Z; Sun J
Nat Commun; 2019 Jul; 10(1):3211. PubMed ID: 31324811
[TBL] [Abstract][Full Text] [Related]
6. In vivo tailor-made protein corona of a prodrug-based nanoassembly fabricated by redox dual-sensitive paclitaxel prodrug for the superselective treatment of breast cancer.
Zhang D; Yang J; Guan J; Yang B; Zhang S; Sun M; Yang R; Zhang T; Zhang R; Kan Q; Zhang H; He Z; Shang L; Sun J
Biomater Sci; 2018 Aug; 6(9):2360-2374. PubMed ID: 30019051
[TBL] [Abstract][Full Text] [Related]
7. Precise engineering of disulfide bond-bridged prodrug nanoassemblies to balance antitumor efficacy and safety.
Sun Y; Wang S; Li Y; Wang D; Zhang Y; Zhang H; Lei H; Liu X; Sun J; Sun B; He Z
Acta Biomater; 2023 Feb; 157():417-427. PubMed ID: 36513247
[TBL] [Abstract][Full Text] [Related]
8. Probing the Role of Connecting Bonds and Modifying Chains in the Rational Design of Prodrug Nanoassemblies.
Wang D; Du C; Wang S; Li L; Liu T; Song J; He Z; Zhai Y; Sun B; Sun J
ACS Appl Mater Interfaces; 2022 Nov; 14(45):51200-51211. PubMed ID: 36397309
[TBL] [Abstract][Full Text] [Related]
9. Hybrid chalcogen bonds in prodrug nanoassemblies provides dual redox-responsivity in the tumor microenvironment.
Liu T; Li L; Wang S; Dong F; Zuo S; Song J; Wang X; Lu Q; Wang H; Zhang H; Cheng M; Liu X; He Z; Sun B; Sun J
Nat Commun; 2022 Nov; 13(1):7228. PubMed ID: 36434014
[TBL] [Abstract][Full Text] [Related]
10. Small changes in the length of diselenide bond-containing linkages exert great influences on the antitumor activity of docetaxel homodimeric prodrug nanoassemblies.
Li L; Zuo S; Dong F; Liu T; Gao Y; Yang Y; Wang X; Sun J; Sun B; He Z
Asian J Pharm Sci; 2021 May; 16(3):337-349. PubMed ID: 34276822
[TBL] [Abstract][Full Text] [Related]
11. Disulfide Bond-Based SN38 Prodrug Nanoassemblies with High Drug Loading and Reduction-Triggered Drug Release for Pancreatic Cancer Therapy.
Zhong ZX; Li XZ; Liu JT; Qin N; Duan HQ; Duan XC
Int J Nanomedicine; 2023; 18():1281-1298. PubMed ID: 36945256
[TBL] [Abstract][Full Text] [Related]
12. Photosensitizer-driven nanoassemblies of homodimeric prodrug for self-enhancing activation and synergistic chemo-photodynamic therapy.
Zhang S; Wang Z; Kong Z; Wang Y; Zhang X; Sun B; Zhang H; Kan Q; He Z; Luo C; Sun J
Theranostics; 2021; 11(12):6019-6032. PubMed ID: 33897896
[TBL] [Abstract][Full Text] [Related]
13. Probing the fluorination effect on the self-assembly characteristics,
Wang X; Yang B; Li L; Liu T; Zuo S; Chi D; He Z; Sun B; Sun J
Theranostics; 2021; 11(16):7896-7910. PubMed ID: 34335971
[No Abstract] [Full Text] [Related]
14. Disulfide/α-Amide-Bridged Doxorubicin Dimeric Prodrug: Effect of Aggregation Structures on pH/GSH Dual-Triggered Drug Release.
Yang C; Liu P
Langmuir; 2024 May; 40(21):11098-11105. PubMed ID: 38739904
[TBL] [Abstract][Full Text] [Related]
15. Tetrasulfide bond boosts the anti-tumor efficacy of dimeric prodrug nanoassemblies.
Zuo S; Liu T; Li L; Xu H; Guo J; Wang Q; Yang Y; He Z; Sun J; Sun B
Cell Rep Med; 2024 Mar; 5(3):101432. PubMed ID: 38387464
[TBL] [Abstract][Full Text] [Related]
16. Self-Assembled Redox Dual-Responsive Prodrug-Nanosystem Formed by Single Thioether-Bridged Paclitaxel-Fatty Acid Conjugate for Cancer Chemotherapy.
Luo C; Sun J; Liu D; Sun B; Miao L; Musetti S; Li J; Han X; Du Y; Li L; Huang L; He Z
Nano Lett; 2016 Sep; 16(9):5401-8. PubMed ID: 27490088
[TBL] [Abstract][Full Text] [Related]
17. The effect of linkers on the self-assembling and anti-tumor efficacy of disulfide-linked doxorubicin drug-drug conjugate nanoparticles.
Wang Y; Wang X; Deng F; Zheng N; Liang Y; Zhang H; He B; Dai W; Wang X; Zhang Q
J Control Release; 2018 Jun; 279():136-146. PubMed ID: 29655991
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
Hou M; Gao YE; Shi X; Bai S; Ma X; Li B; Xiao B; Xue P; Kang Y; Xu Z
Acta Biomater; 2018 Sep; 77():228-239. PubMed ID: 30006314
[TBL] [Abstract][Full Text] [Related]
19. Zwitterion-Driven Shape Program of Prodrug Nanoassemblies with High Stability, High Tumor Accumulation, and High Antitumor Activity.
Li G; Sun B; Zheng S; Xu L; Tao W; Zhao D; Yu J; Fu S; Zhang X; Zhang H; Zhai Y; Luo C; Ding H; He Z; Sun J
Adv Healthc Mater; 2021 Dec; 10(23):e2101407. PubMed ID: 34601824
[TBL] [Abstract][Full Text] [Related]
20. ROS-Activated homodimeric podophyllotoxin nanomedicine with self-accelerating drug release for efficient cancer eradication.
Liang B; Zhou D
Drug Deliv; 2021 Dec; 28(1):2361-2372. PubMed ID: 34747277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
